Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2015

Mar 27, 2015

29777_dirs_2015-03-27_64abe0b0-f5ce-4eec-b7ca-12636cbbfabe.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2015-03-26

Reporting Person: White J. Scott (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-03-26 Common shares without par value M 10100 $23.5643 Acquired 99702 Direct
2015-03-26 Common shares without par value M 8500 $21.2194 Acquired 108202 Direct
2015-03-26 Common shares without par value S 5068 $46.67 Disposed 103134 Direct
2015-03-26 Common shares without par value S 800 $46.68 Disposed 102334 Direct
2015-03-26 Common shares without par value S 6515 $46.681 Disposed 95819 Direct
2015-03-26 Common shares without par value S 100 $46.685 Disposed 95719 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-03-26 Option (right to buy) $23.5643 M 10100 Disposed 2015-06-29 Common shares (10100) Direct
2015-03-26 Option (right to buy) $21.2194 M 8500 Disposed 2016-02-16 Common shares (8500) Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.